TY - JOUR AU - Antoni, S. AU - Ferlay, J. AU - Soerjomataram, I. PY - 2017 DA - 2017// JO - Eur Urol VL - 71 UR - https://doi.org/10.1016/j.eururo.2016.06.010 DO - 10.1016/j.eururo.2016.06.010 ID - Antoni2017 ER - TY - JOUR AU - Chen, W. AU - Zheng, R. AU - Baade, P. D. PY - 2016 DA - 2016// TI - Cancer statistics in China, 2015 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21338 DO - 10.3322/caac.21338 ID - Chen2016 ER - TY - JOUR AU - Montironi, R. AU - Cheng, L. AU - Scarpelli, M. AU - Lopez-Beltran, A. PY - 2016 DA - 2016// TI - Pathology and genetics: tumours of the urinary system and male genital system: clinical implications of the 4th Edition of the WHO classification and beyond JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2016.03.011 DO - 10.1016/j.eururo.2016.03.011 ID - Montironi2016 ER - TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Locasale, J. W. AU - Cantley, L. C. AU - Vander Heiden, M. G. PY - 2009 DA - 2009// TI - Cancer’s insatiable appetite JO - Nat Biotechnol VL - 27 UR - https://doi.org/10.1038/nbt1009-916 DO - 10.1038/nbt1009-916 ID - Locasale2009 ER - TY - JOUR AU - Röhrig, F. AU - Schulze, A. PY - 2016 DA - 2016// TI - The multifaceted roles of fatty acid synthesis in cancer JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.89 DO - 10.1038/nrc.2016.89 ID - Röhrig2016 ER - TY - JOUR AU - Vander Heiden, M. G. AU - Cantley, L. C. AU - Thompson, C. B. PY - 2009 DA - 2009// TI - Understanding the Warburg effect: the metabolic requirements of cell proliferation JO - Science VL - 324 UR - https://doi.org/10.1126/science.1160809 DO - 10.1126/science.1160809 ID - Vander Heiden2009 ER - TY - JOUR AU - Massari, F. AU - Ciccarese, C. AU - Santoni, M. PY - 2016 DA - 2016// TI - Metabolic phenotype of bladder cancer JO - Cancer Treat Rev VL - 45 UR - https://doi.org/10.1016/j.ctrv.2016.03.005 DO - 10.1016/j.ctrv.2016.03.005 ID - Massari2016 ER - TY - JOUR AU - Cheng, S. AU - Wang, G. AU - Wang, Y. PY - 2019 DA - 2019// TI - Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer JO - Clin Sci (Lond). VL - 133 UR - https://doi.org/10.1042/CS20190587 DO - 10.1042/CS20190587 ID - Cheng2019 ER - TY - JOUR AU - Zhou, Q. AU - Zhan, H. AU - Lin, F. PY - 2019 DA - 2019// TI - LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression JO - Biosci Rep. VL - 39 UR - https://doi.org/10.1042/bsr20182372 DO - 10.1042/bsr20182372 ID - Zhou2019 ER - TY - JOUR AU - Stachowiak, M. AU - Szymanski, M. AU - Ornoch, A. PY - 2020 DA - 2020// TI - SWI/SNF chromatin remodeling complex and glucose metabolism are deregulated in advanced bladder cancer JO - IUBMB Life VL - 72 UR - https://doi.org/10.1002/iub.2254 DO - 10.1002/iub.2254 ID - Stachowiak2020 ER - TY - JOUR AU - Li, T. AU - Jiang, D. AU - Wu, K. PY - 2020 DA - 2020// TI - p62 promotes bladder cancer cell growth by activating KEAP1/NRF2-dependent antioxidative response JO - Cancer Sci VL - 111 UR - https://doi.org/10.1111/cas.14321 DO - 10.1111/cas.14321 ID - Li2020 ER - TY - JOUR AU - Vantaku, V. AU - Putluri, V. AU - Bader, D. A. PY - 2019 DA - 2019// TI - Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression JO - Oncogene UR - https://doi.org/10.1038/s41388-019-0902-7 DO - 10.1038/s41388-019-0902-7 ID - Vantaku2019 ER - TY - JOUR AU - Loras, A. AU - Trassierra, M. AU - Sanjuan-Herráez, D. PY - 2018 DA - 2018// TI - Bladder cancer recurrence surveillance by urine metabolomics analysis JO - Sci Rep. VL - 8 UR - https://doi.org/10.1038/s41598-018-27538-3 DO - 10.1038/s41598-018-27538-3 ID - Loras2018 ER - TY - JOUR AU - Cheng, Y. AU - Yang, X. AU - Deng, X. PY - 2015 DA - 2015// TI - Metabolomics in bladder cancer: a systematic review JO - Int J Clin Exp Med. VL - 8 ID - Cheng2015 ER - TY - JOUR AU - Piyarathna, D. W. B. AU - Rajendiran, T. M. AU - Putluri, V. PY - 2018 DA - 2018// TI - Distinct lipidomic landscapes associated with clinical stages of urothelial cancer of the bladder JO - Eur Urol Focus. VL - 4 UR - https://doi.org/10.1016/j.euf.2017.04.005 DO - 10.1016/j.euf.2017.04.005 ID - Piyarathna2018 ER - TY - JOUR AU - Szklarczyk, D. AU - Morris, J. H. AU - Cook, H. PY - 2017 DA - 2017// TI - The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible JO - Nucleic Acids Res VL - 45 UR - https://doi.org/10.1093/nar/gkw937 DO - 10.1093/nar/gkw937 ID - Szklarczyk2017 ER - TY - JOUR AU - Zhou, Y. AU - Jin, Z. AU - Wang, C. PY - 2019 DA - 2019// TI - Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p JO - Biomed Pharmacother VL - 120 UR - https://doi.org/10.1016/j.biopha.2019.109449 DO - 10.1016/j.biopha.2019.109449 ID - Zhou2019 ER - TY - JOUR AU - Robertson, A. G. AU - Kim, J. AU - Al-Ahmadie, H. PY - 2018 DA - 2018// TI - Comprehensive molecular characterization of muscle-invasive bladder cancer JO - Cell VL - 174 UR - https://doi.org/10.1016/j.cell.2018.07.036 DO - 10.1016/j.cell.2018.07.036 ID - Robertson2018 ER - TY - JOUR AU - Shen, C. AU - Liu, J. AU - Wang, J. PY - 2020 DA - 2020// TI - Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma JO - Int Immunopharmacol VL - 81 UR - https://doi.org/10.1016/j.intimp.2020.106274 DO - 10.1016/j.intimp.2020.106274 ID - Shen2020 ER - TY - JOUR AU - Chanput, W. AU - Mes, J. J. AU - Wichers, H. J. PY - 2014 DA - 2014// TI - THP-1 cell line: an in vitro cell model for immune modulation approach JO - Int Immunopharmacol VL - 23 UR - https://doi.org/10.1016/j.intimp.2014.08.002 DO - 10.1016/j.intimp.2014.08.002 ID - Chanput2014 ER - TY - JOUR AU - Choi, W. AU - Porten, S. AU - Kim, S. PY - 2014 DA - 2014// TI - Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy JO - Cancer Cell VL - 25 UR - https://doi.org/10.1016/j.ccr.2014.01.009 DO - 10.1016/j.ccr.2014.01.009 ID - Choi2014 ER - TY - JOUR AU - Sjödahl, G. AU - Lauss, M. AU - Lövgren, K. PY - 2012 DA - 2012// TI - A molecular taxonomy for urothelial carcinoma JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0077-T DO - 10.1158/1078-0432.CCR-12-0077-T ID - Sjödahl2012 ER - TY - JOUR AU - Choi, W. AU - Czerniak, B. AU - Ochoa, A. PY - 2014 DA - 2014// TI - Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer JO - Nat Rev Urol. VL - 11 UR - https://doi.org/10.1038/nrurol.2014.129 DO - 10.1038/nrurol.2014.129 ID - Choi2014 ER - TY - JOUR AU - Conde, V. R. AU - Oliveira, P. F. AU - Nunes, A. R. PY - 2015 DA - 2015// TI - The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism JO - Exp Cell Res VL - 335 UR - https://doi.org/10.1016/j.yexcr.2015.04.007 DO - 10.1016/j.yexcr.2015.04.007 ID - Conde2015 ER - TY - JOUR AU - Wu, X. AU - Li, X. AU - Fu, Q. PY - 2017 DA - 2017// TI - AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program JO - J Exp Med VL - 214 UR - https://doi.org/10.1084/jem.20160903 DO - 10.1084/jem.20160903 ID - Wu2017 ER - TY - JOUR AU - Khayami, R. AU - Hashemi, S. R. AU - Kerachian, M. A. PY - 2020 DA - 2020// TI - Role of aldo-keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential JO - J Cell Mol Med VL - 24 UR - https://doi.org/10.1111/jcmm.15581 DO - 10.1111/jcmm.15581 ID - Khayami2020 ER - TY - JOUR AU - Gu, S. AU - Feng, X. H. PY - 2018 DA - 2018// TI - TGF-β signaling in cancer JO - Acta Biochim Biophys Sin (Shanghai) VL - 50 UR - https://doi.org/10.1093/abbs/gmy092 DO - 10.1093/abbs/gmy092 ID - Gu2018 ER - TY - JOUR AU - Bierie, B. AU - Moses, H. L. PY - 2006 DA - 2006// TI - Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer JO - Nat Rev Cancer VL - 6 UR - https://doi.org/10.1038/nrc1926 DO - 10.1038/nrc1926 ID - Bierie2006 ER - TY - JOUR AU - Dumont, N. AU - Arteaga, C. L. PY - 2003 DA - 2003// TI - Targeting the TGF beta signaling network in human neoplasia JO - Cancer Cell VL - 3 UR - https://doi.org/10.1016/s1535-6108(03)00135-1 DO - 10.1016/s1535-6108(03)00135-1 ID - Dumont2003 ER - TY - JOUR AU - Schmierer, B. AU - Hill, C. S. PY - 2007 DA - 2007// TI - TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility JO - Nat Rev Mol Cell Biol VL - 8 UR - https://doi.org/10.1038/nrm2297 DO - 10.1038/nrm2297 ID - Schmierer2007 ER - TY - JOUR AU - Massagué, J. AU - Seoane, J. AU - Wotton, D. PY - 2005 DA - 2005// TI - Smad transcription factors JO - Genes Dev VL - 19 UR - https://doi.org/10.1101/gad.1350705 DO - 10.1101/gad.1350705 ID - Massagué2005 ER - TY - JOUR AU - Feng, X. H. AU - Derynck, R. PY - 2005 DA - 2005// TI - Specificity and versatility in tgf-beta signaling through Smads JO - Annu Rev Cell Dev Biol VL - 21 UR - https://doi.org/10.1146/annurev.cellbio.21.022404.142018 DO - 10.1146/annurev.cellbio.21.022404.142018 ID - Feng2005 ER - TY - JOUR AU - Mazza, G. AU - Telese, A. AU - Al-Akkad, W. PY - 2019 DA - 2019// TI - Cirrhotic human liver extracellular matrix 3d scaffolds promote smad-dependent TGF-β1 epithelial mesenchymal transition JO - Cells VL - 9 UR - https://doi.org/10.3390/cells9010083 DO - 10.3390/cells9010083 ID - Mazza2019 ER - TY - JOUR AU - Xu, J. AU - Lamouille, S. AU - Derynck, R. PY - 2009 DA - 2009// TI - TGF-beta-induced epithelial to mesenchymal transition JO - Cell Res VL - 19 UR - https://doi.org/10.1038/cr.2009.5 DO - 10.1038/cr.2009.5 ID - Xu2009 ER - TY - JOUR AU - Xiong, R. AU - Gao, J. L. AU - Yin, T. PY - 2019 DA - 2019// TI - G3BP1 activates the TGF-β/Smad signaling pathway to promote gastric cancer JO - Onco Targets Ther. VL - 2 UR - https://doi.org/10.2147/OTT.S213728 DO - 10.2147/OTT.S213728 ID - Xiong2019 ER - TY - JOUR AU - Soukupova, J. AU - Malfettone, A. AU - Hyroššová, P. PY - 2017 DA - 2017// TI - Role of the Transforming Growth Factor-β in regulating hepatocellular carcinoma oxidative metabolism JO - Sci Rep. VL - 7 UR - https://doi.org/10.1038/s41598-017-12837-y DO - 10.1038/s41598-017-12837-y ID - Soukupova2017 ER - TY - JOUR AU - Hua, W. AU - Dijke, P. AU - Kostidis, S. PY - 2020 DA - 2020// TI - TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer JO - Cell Mol Life Sci VL - 77 UR - https://doi.org/10.1007/s00018-019-03398-6 DO - 10.1007/s00018-019-03398-6 ID - Hua2020 ER - TY - JOUR AU - Qi, Y. AU - Xu, R. PY - 2018 DA - 2018// TI - Roles of PLODs in collagen synthesis and cancer progression JO - Front Cell Dev Biol. VL - 28 UR - https://doi.org/10.3389/fcell.2018.00066 DO - 10.3389/fcell.2018.00066 ID - Qi2018 ER - TY - JOUR AU - Yamada, Y. AU - Kato, M. AU - Arai, T. PY - 2019 DA - 2019// TI - Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target JO - Mol Oncol. VL - 13 UR - https://doi.org/10.1002/1878-0261.12532 DO - 10.1002/1878-0261.12532 ID - Yamada2019 ER - TY - JOUR AU - Mello, A. A. AU - Leal, M. F. AU - Rey, J. A. PY - 2015 DA - 2015// TI - Deregulated expression of SRC, LYN and CKB kinases by DNA methylation and its potential role in gastric cancer invasiveness and metastasis JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0140492 DO - 10.1371/journal.pone.0140492 ID - Mello2015 ER - TY - JOUR AU - Wang, Z. AU - Han, G. AU - Liu, Q. PY - 2018 DA - 2018// TI - Silencing of PYGB suppresses growth and promotes the apoptosis of prostate cancer cells via the NF-κB/Nrf2 signaling pathway JO - Mol Med Rep. VL - 18 UR - https://doi.org/10.3892/mmr.2018.9388 DO - 10.3892/mmr.2018.9388 ID - Wang2018 ER - TY - JOUR AU - Xiao, L. AU - Wang, W. AU - Huangfu, Q. PY - 2020 DA - 2020// TI - PYGB facilitates cell proliferation and invasion in non-small cell lung cancer through activating Wnt/β-catenin signaling JO - Biochem Cell Biol UR - https://doi.org/10.1139/bcb-2019-0445 DO - 10.1139/bcb-2019-0445 ID - Xiao2020 ER - TY - JOUR AU - Murata, T. AU - Shimizu, K. AU - Watanabe, Y. PY - 2010 DA - 2010// TI - Expression and role of phosphodiesterase 5 in human malignant melanoma cell line JO - Anticancer Res VL - 30 ID - Murata2010 ER - TY - JOUR AU - Sponziello, M. AU - Verrienti, A. AU - Rosignolo, F. PY - 2015 DA - 2015// TI - PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells JO - Endocrine VL - 50 UR - https://doi.org/10.1007/s12020-015-0586-x DO - 10.1007/s12020-015-0586-x ID - Sponziello2015 ER - TY - JOUR AU - Tinsley, H. N. AU - Gary, B. D. AU - Keeton, A. B. PY - 2011 DA - 2011// TI - Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells JO - Cancer Prev Res (Phila). VL - 4 UR - https://doi.org/10.1158/1940-6207.CAPR-11-0095 DO - 10.1158/1940-6207.CAPR-11-0095 ID - Tinsley2011 ER -